Dr. Ekwi D. Nsongmayi earned his Ph.D. in Microbiology from the University of Buea, Cameroon, in 2022. During his doctoral studies, he received a scholarship from the Centre for Advancement of Molecular Medicine for Africa (CAMMA), Albany, New York, USA, where he underwent advanced training in molecular diagnostics, bioinformatics, and phylogenetic analysis. His training included the application of BLAST, ClustalW, and MEGA X software for molecular data analysis and interpretation. Dr. Nsongmayi currently serves as Leader of the Microbiology and Antimicrobial Resistance (MARE) Research Group at the Translational Research and Development Foundation (TREND Foundation). His research focuses on public health microbiology, particularly the role of the human microbiota in health and disease, and the development of novel antimicrobial peptides and probiotics as sustainable strategies to combat antimicrobial resistance and reduce the transmission of infectious diseases. He is a Lecturer-Researcher and Pedagogic Coordinator for Biomedical Sciences in the Department of Biomedical and Medical Sciences at the University of Ebolowa. Dr. Nsongmayi has actively participated in numerous national and international scientific conferences and workshops on the diagnosis, prevention, and control of infectious diseases, including events held in San Diego, California (USA), the 9th International Conference on Health, Medicine and Life Sciences (MEDLIFE 2024) in Nanjing, China, and the 2024 Conference of the Cameroon Society for Microbiology (SOCAMI) in Yaoundé, Cameroon, which focused on antimicrobial resistance. He is a member of several professional and scientific organizations, including the Cameroon Society for Microbiology (SOCAMI), the Human Microbiome and Probiotic Research Team at the University of Buea, the Association Scientifique Internationale des Biologies Techniques (ASSITEB), the Association Camerounaise des Biologies Techniques (ASCATEB), and the American Public Health Association (APHA). Through his teaching, research, and professional engagements, he continues to contribute to advancing microbiological research and strengthening efforts to address infectious diseases and antimicrobial resistance in Cameroon and beyond.